Angiography Equipment Market Size, Share, Growth, and Industry Analysis, By Types (X-Ray Angiography, CT Angiography, MR Angiography, Others), By Applications (Hospitals and Clinics, Diagnostic and Imaging Centers, Research Institutes) , and Regional Insights and Forecast to 2034

Angiography Equipment Market Size

The Global Angiography Equipment Market size was USD 12.95 billion in 2024 and is projected to reach USD 13.61 billion in 2025, USD 14.3 billion in 2026, and USD 21.29 billion by 2034, exhibiting a 5.1% growth rate during the forecast period [2025-2034]. Nearly 40% of the market demand is concentrated in North America, while Europe contributes 30%, Asia-Pacific holds 22%, and Middle East & Africa represents 8% of the share.

The US Angiography Equipment Market is expanding steadily, supported by more than 45% hospital adoption of digital angiography systems and over 50% of coronary procedures utilizing advanced imaging. Around 38% of diagnostic centers in the US have integrated portable angiography equipment, while nearly 30% of investments are directed toward AI-driven imaging innovations, highlighting strong regional growth momentum.

Key Findings

• Market Size: USD 12.95 billion (2024), USD 13.61 billion (2025), USD 21.29 billion (2034), 5.1% CAGR – steady growth projected.
• Growth Drivers: More than 55% hospitals rely on advanced angiography, 48% patients prefer minimally invasive imaging, 32% investments target AI-based solutions.
• Trends: Over 60% adoption of flat-panel detectors, 40% preference for mobile systems, 35% focus on radiation reduction technologies.
• Key Players: GE Healthcare, Siemens, Philips, Medtronic, Boston Scientific & more.
• Regional Insights: North America leads the angiography equipment market with 40% share, driven by advanced hospitals. Europe follows at 30% with strong adoption. Asia-Pacific holds 22% fueled by rising procedures, while Middle East & Africa captures 8% supported by expanding healthcare facilities, together making up 100% of the global market.
• Challenges: 37% hospitals cite high equipment cost, 36% workforce shortages, 28% face delayed procedures due to lack of trained professionals.
• Industry Impact: More than 45% upgrades underway globally, 52% growth in minimally invasive adoption, 40% improved access through mobile angiography systems.
• Recent Developments: Over 20% new products emphasize AI, 32% focus on portability, 25% target radiation reduction, 18% highlight hybrid imaging systems.

The angiography equipment market is undergoing significant transformation with increasing adoption of digital platforms, mobile angiography units, and AI-integrated systems. Over 55% of hospitals worldwide are replacing conventional systems with next-generation devices. Nearly 45% of angiography procedures are coronary-focused, while 30% are neurological and peripheral-based. More than 35% of manufacturers are investing in radiation safety innovations, and around 40% of diagnostic centers globally prefer mobile solutions, reflecting the market’s strong evolution toward advanced, efficient, and patient-centered imaging solutions.

Angiography Equipment Market Trends

The angiography equipment market is witnessing notable advancements, with hospitals contributing over 60% of overall adoption due to rising demand for precise cardiovascular imaging. Mobile angiography systems are gaining traction, holding nearly 25% share as they enable improved patient accessibility and faster diagnostics. North America dominates the market with approximately 40% share, driven by higher investments in advanced imaging technology and early diagnosis rates. Europe follows closely with nearly 30% share, while Asia-Pacific accounts for more than 20% owing to rapid expansion of healthcare infrastructure. Within product segmentation, angiography catheters and guidewires collectively hold more than 35% share, highlighting their critical role in minimally invasive procedures. The adoption of digital flat-panel detector (FPD) angiography systems surpasses 55% as healthcare providers prioritize accuracy and reduced radiation exposure. Moreover, more than 45% of angiography procedures are focused on coronary applications, reflecting growing cases of cardiovascular diseases worldwide. These percentages underscore the strong momentum in the angiography equipment market, fueled by higher usage in hospitals, demand for advanced imaging systems, and significant penetration across developed and emerging regions.

Angiography Equipment Market Dynamics

OPPORTUNITY

Expansion in Hospital Infrastructure

Around 58% of global healthcare facilities are upgrading imaging departments, opening strong opportunities for angiography equipment. Nearly 42% of new hospital projects emphasize advanced cardiovascular imaging, while more than 35% of private healthcare players are investing in digital angiography systems to meet growing patient needs. This expansion strongly supports wider market penetration.

DRIVERS

Rising Prevalence of Cardiovascular Disorders

More than 47% of global mortality is linked to cardiovascular diseases, pushing the demand for reliable angiography equipment. Over 55% of interventional cardiology procedures involve angiography imaging, while nearly 30% of diagnostic centers now integrate mobile angiography units to expand patient access. This rising disease burden significantly fuels the market’s growth.

RESTRAINTS

"High Installation and Maintenance Costs"

Nearly 40% of medium-scale healthcare facilities delay adoption of angiography equipment due to cost barriers. Around 33% of hospitals in developing regions cite operational expenses as a major restraint. These high costs limit accessibility, especially for institutions where budgets are restricted, slowing down broader implementation of advanced angiography systems.

CHALLENGE

"Shortage of Skilled Professionals"

Approximately 36% of hospitals report insufficient trained specialists to operate angiography equipment effectively. Around 28% of procedures face delays due to workforce shortages, and over 25% of facilities highlight inadequate training programs. This shortage of skilled professionals poses a critical challenge to maximizing equipment efficiency and ensuring accurate patient outcomes.

Segmentation Analysis

The global angiography equipment market, valued at USD 13.61 Billion in 2025, is projected to reach USD 21.29 Billion by 2034, growing at a CAGR of 5.1%. By type, X-Ray angiography holds the largest share with over 40%, followed by CT angiography with nearly 28%, MR angiography at around 20%, and others at 12%. Each type shows distinct adoption patterns with X-Ray angiography dominating due to high procedural volume, CT angiography gaining traction for enhanced imaging, and MR angiography expanding with improved non-invasive diagnostics. By application, hospitals and clinics lead with nearly 55% share, diagnostic and imaging centers hold 30%, and research institutes account for about 15%. In 2025, hospitals and clinics represent the largest revenue contribution, followed by diagnostic centers and research institutes, each showing steady CAGR across the forecast period.

By Type

X-Ray Angiography

X-Ray angiography remains the most widely adopted type, accounting for more than 40% of global usage due to its accuracy, cost-effectiveness, and accessibility in both developed and emerging economies. Its application spans coronary, cerebral, and peripheral imaging, supporting large-scale adoption.

X-Ray Angiography held the largest share in the angiography equipment market, accounting for USD 5.44 Billion in 2025, representing 40% of the total market. This segment is expected to grow at a CAGR of 4.8% from 2025 to 2034, driven by increasing cardiovascular procedures, rising hospital integration, and cost efficiency.

Top 3 Major Dominant Countries in the X-Ray Angiography Segment

• United States led the X-Ray angiography segment with a market size of USD 1.25 Billion in 2025, holding a 23% share and expected to grow at a CAGR of 5.0% due to advanced healthcare systems and rising patient volumes.
• Germany followed with USD 0.78 Billion in 2025, securing a 14% share, expanding at a CAGR of 4.6% on the back of strong hospital infrastructure and advanced imaging adoption.
• China held USD 0.71 Billion in 2025, accounting for 13% share, expected to grow at 5.2% CAGR due to rapid healthcare investments and growing cardiovascular cases.

CT Angiography

CT angiography captures nearly 28% of the market share, gaining preference due to its high-resolution imaging and ability to detect vascular anomalies non-invasively. It is increasingly used in emergency diagnostics and screening.

CT Angiography accounted for USD 3.81 Billion in 2025, representing 28% share of the total market. This segment is projected to grow at a CAGR of 5.3% from 2025 to 2034, driven by demand for faster imaging, advanced diagnostic capabilities, and integration into large healthcare networks.

Top 3 Major Dominant Countries in the CT Angiography Segment

• United States led with USD 0.95 Billion in 2025, holding a 25% share, growing at a CAGR of 5.5% fueled by rising emergency care adoption.
• Japan followed with USD 0.63 Billion in 2025, capturing a 16% share, expected to grow at 5.1% CAGR due to technological advancements and aging population demand.
• India recorded USD 0.49 Billion in 2025, accounting for 13% share, forecasted to grow at 5.7% CAGR due to expanding diagnostic imaging centers.

MR Angiography

MR angiography secures around 20% of the market, preferred for its radiation-free imaging and detailed vascular analysis. It is highly adopted in advanced hospitals and research facilities, particularly for neurological applications.

MR Angiography represented USD 2.72 Billion in 2025, accounting for 20% share of the angiography equipment market. This segment is expected to grow at a CAGR of 5.4% from 2025 to 2034, supported by the rise in non-invasive diagnostics and safer imaging demand.

Top 3 Major Dominant Countries in the MR Angiography Segment

• United States dominated with USD 0.82 Billion in 2025, holding a 30% share, expected to grow at a CAGR of 5.5% driven by high R&D and advanced hospital adoption.
• United Kingdom followed with USD 0.44 Billion in 2025, representing 16% share, growing at 5.3% CAGR due to increasing non-invasive imaging usage.
• France stood at USD 0.38 Billion in 2025, securing 14% share, with a CAGR of 5.2% supported by advanced neurological diagnostics demand.

Others

Other angiography technologies, including hybrid imaging and advanced portable systems, represent about 12% share of the market. These are increasingly adopted for specialized procedures and outpatient services.

Others accounted for USD 1.63 Billion in 2025, representing 12% of the angiography equipment market. This segment is expected to expand at a CAGR of 4.7% from 2025 to 2034, driven by hybrid applications and adoption in smaller diagnostic centers.

Top 3 Major Dominant Countries in the Others Segment

• China led with USD 0.42 Billion in 2025, capturing 26% share, expected to grow at 4.9% CAGR due to expanding outpatient healthcare adoption.
• Brazil followed with USD 0.29 Billion in 2025, holding 18% share, projected to grow at 4.8% CAGR with increasing demand in secondary healthcare centers.
• Italy recorded USD 0.24 Billion in 2025, with 15% share, expanding at 4.6% CAGR driven by hybrid imaging integration.

By Application

Hospitals and Clinics

Hospitals and clinics dominate the market with nearly 55% share, as angiography equipment is a core component for cardiovascular and neurological procedures. Increasing patient volumes and infrastructure upgrades sustain their leading position.

Hospitals and Clinics accounted for USD 7.48 Billion in 2025, representing 55% of the angiography equipment market. This segment is forecasted to grow at a CAGR of 5.0% from 2025 to 2034, driven by high patient inflow, procedure diversity, and government healthcare spending.

Top 3 Major Dominant Countries in the Hospitals and Clinics Segment

• United States led with USD 1.85 Billion in 2025, holding a 25% share, expected to grow at a CAGR of 5.2% due to advanced infrastructure and high cardiovascular cases.
• China followed with USD 1.31 Billion in 2025, securing 17% share, projected to grow at 5.4% CAGR with strong healthcare investments.
• Germany stood at USD 0.86 Billion in 2025, representing 12% share, growing at 5.0% CAGR due to expanding clinical imaging applications.

Diagnostic and Imaging Centers

Diagnostic and imaging centers hold nearly 30% market share, catering to outpatient services and specialized imaging needs. Increasing affordability and rapid patient turnaround drive their relevance in the market.

Diagnostic and Imaging Centers represented USD 4.08 Billion in 2025, accounting for 30% share. This segment is expected to grow at a CAGR of 5.2% from 2025 to 2034, supported by the rise in outpatient diagnostics and expansion of private imaging facilities.

Top 3 Major Dominant Countries in the Diagnostic and Imaging Centers Segment

• United States led with USD 1.06 Billion in 2025, representing 26% share, growing at 5.3% CAGR driven by advanced outpatient diagnostics.
• India followed with USD 0.78 Billion in 2025, accounting for 19% share, projected to grow at 5.5% CAGR due to increasing diagnostic center penetration.
• Japan recorded USD 0.62 Billion in 2025, holding 15% share, with 5.0% CAGR expansion supported by rising demand for early detection imaging.

Research Institutes

Research institutes account for nearly 15% of market share, focused on developing advanced imaging technologies and supporting clinical trials. Their role is critical in fostering innovation and specialized applications.

Research Institutes generated USD 2.04 Billion in 2025, accounting for 15% share of the global market. This segment is anticipated to grow at a CAGR of 5.3% from 2025 to 2034, fueled by investments in innovation, academic collaborations, and demand for advanced imaging research.

Top 3 Major Dominant Countries in the Research Institutes Segment

• United States dominated with USD 0.66 Billion in 2025, representing 32% share, growing at a CAGR of 5.5% due to strong academic and research investments.
• United Kingdom followed with USD 0.41 Billion in 2025, capturing 20% share, expanding at 5.2% CAGR with increased government funding for medical research.
• France stood at USD 0.37 Billion in 2025, holding 18% share, growing at 5.3% CAGR driven by collaborative imaging studies.

Angiography Equipment Market Regional Outlook

The global angiography equipment market, valued at USD 13.61 Billion in 2025, is projected to reach USD 21.29 Billion by 2034 with a CAGR of 5.1%. Regionally, North America dominates with 40% share, followed by Europe at 30%, Asia-Pacific at 22%, and Middle East & Africa at 8%. Each region presents unique growth drivers such as advanced healthcare adoption in North America, expanding hospital networks in Europe, rising cardiovascular cases in Asia-Pacific, and infrastructure development in the Middle East & Africa.

North America

North America holds the largest share in the angiography equipment market, accounting for USD 5.44 Billion in 2025, representing 40% of the total market. This dominance is fueled by the strong presence of advanced hospitals, high prevalence of cardiovascular diseases, and adoption of digital angiography systems. More than 65% of hospitals in this region already utilize flat-panel detector systems, and nearly 50% of coronary procedures rely on angiography equipment. Growing focus on minimally invasive imaging strengthens regional market growth further.

North America Market Size, Share and CAGR: North America held the largest share in the angiography equipment market, accounting for USD 5.44 Billion in 2025, representing 40% of the total market. This segment is expected to grow at a CAGR of 5.0% from 2025 to 2034, driven by strong technology integration, high healthcare spending, and expanding patient base.

North America - Major Dominant Countries in the Angiography Equipment Market

• United States led North America with a market size of USD 3.12 Billion in 2025, holding a 57% share and expected to grow at a CAGR of 5.2% due to advanced infrastructure and high diagnostic demand.
• Canada recorded USD 1.01 Billion in 2025, representing 19% share, projected to expand at 4.9% CAGR supported by increased adoption of digital systems.
• Mexico accounted for USD 0.71 Billion in 2025, holding 13% share, growing at 4.8% CAGR driven by improving healthcare facilities.

Europe

Europe represents 30% of the angiography equipment market, amounting to USD 4.08 Billion in 2025. This region benefits from advanced hospital infrastructure, strong government support, and widespread adoption of minimally invasive procedures. Over 55% of hospitals in Europe have upgraded to digital angiography systems, and nearly 40% of total cardiac imaging procedures in the region use angiography equipment. Increasing prevalence of lifestyle-related cardiovascular conditions supports continued growth.

Europe Market Size, Share and CAGR: Europe held a significant share in the angiography equipment market, accounting for USD 4.08 Billion in 2025, representing 30% of the total market. This segment is expected to grow at a CAGR of 5.2% from 2025 to 2034, driven by technological advancements, improved healthcare access, and aging populations.

Europe - Major Dominant Countries in the Angiography Equipment Market

• Germany led Europe with USD 1.22 Billion in 2025, holding 30% share, expanding at a CAGR of 5.0% due to high hospital adoption.
• France followed with USD 0.98 Billion in 2025, representing 24% share, growing at 5.1% CAGR supported by public healthcare investments.
• United Kingdom accounted for USD 0.83 Billion in 2025, securing 20% share, with 5.2% CAGR fueled by diagnostic innovation.

Asia-Pacific

Asia-Pacific contributes 22% share of the angiography equipment market, valued at USD 2.99 Billion in 2025. This growth is driven by increasing cardiovascular disease cases, rising healthcare investments, and improving hospital infrastructure. More than 45% of angiography adoption in the region comes from urban hospitals, while private diagnostic centers contribute over 30%. Growing focus on early detection and non-invasive imaging fuels regional expansion significantly.

Asia-Pacific Market Size, Share and CAGR: Asia-Pacific accounted for USD 2.99 Billion in 2025, representing 22% share of the global market. This segment is projected to grow at a CAGR of 5.4% from 2025 to 2034, supported by rapid healthcare development, growing medical tourism, and government funding initiatives.

Asia-Pacific - Major Dominant Countries in the Angiography Equipment Market

• China led Asia-Pacific with USD 1.11 Billion in 2025, holding 37% share, expected to grow at 5.6% CAGR due to expanding hospital capacity.
• India recorded USD 0.86 Billion in 2025, representing 29% share, growing at 5.7% CAGR with increasing diagnostic centers.
• Japan accounted for USD 0.69 Billion in 2025, holding 23% share, expected to grow at 5.3% CAGR supported by advanced technology adoption.

Middle East & Africa

Middle East & Africa holds 8% share of the angiography equipment market, valued at USD 1.09 Billion in 2025. This region shows steady adoption, with more than 40% of angiography demand arising from private healthcare facilities. Increased investment in healthcare infrastructure and the rising prevalence of cardiovascular diseases are accelerating demand, particularly in urban areas.

Middle East & Africa Market Size, Share and CAGR: Middle East & Africa accounted for USD 1.09 Billion in 2025, representing 8% of the angiography equipment market. This segment is anticipated to grow at a CAGR of 4.9% from 2025 to 2034, supported by hospital expansion projects, urbanization, and demand for modern diagnostic imaging.

Middle East & Africa - Major Dominant Countries in the Angiography Equipment Market

• Saudi Arabia led with USD 0.36 Billion in 2025, representing 33% share, projected to grow at 5.0% CAGR with government healthcare investments.
• South Africa followed with USD 0.28 Billion in 2025, holding 26% share, expected to grow at 4.8% CAGR due to rising diagnostic adoption.
• United Arab Emirates recorded USD 0.21 Billion in 2025, accounting for 19% share, expanding at 4.9% CAGR supported by medical tourism and infrastructure upgrades.

List of Key Angiography Equipment Market Companies Profiled

Investment Analysis and Opportunities in Angiography Equipment Market

Investments in the angiography equipment market are witnessing strong momentum, with over 35% of total funding directed toward digital imaging upgrades and flat-panel detector technology. Nearly 28% of new investment flows into Asia-Pacific, supported by expanding hospital infrastructure and medical tourism. In Europe, about 22% of investments focus on upgrading existing angiography labs, while North America contributes nearly 30% to advanced minimally invasive systems. With more than 45% of hospitals aiming to replace outdated angiography units, significant opportunities exist for equipment manufacturers. Additionally, nearly 20% of venture capital is flowing into startups developing AI-powered angiography imaging tools, creating high-value growth opportunities across global markets.

New Products Development

Product development in the angiography equipment market is accelerating, with more than 40% of manufacturers focusing on AI integration for improved diagnostic accuracy. Around 32% of new product launches emphasize portable and mobile angiography units, addressing the rising demand for flexible healthcare solutions. Nearly 25% of product innovation is concentrated on radiation reduction technologies, aligning with global safety standards. In North America, more than 38% of hospitals are adopting next-generation angiography systems, while Asia-Pacific accounts for nearly 30% of new product uptake. This growing wave of innovation highlights the industry’s focus on enhancing precision, efficiency, and patient safety.

Recent Developments

• GE Healthcare: Introduced an advanced digital angiography system integrating AI, improving diagnostic efficiency by over 20% in early trials, and significantly reducing scan time for cardiovascular imaging.
• Siemens: Launched a hybrid angiography suite combining CT and MR features, adopted by 15% of top hospitals in Europe, enhancing clinical outcomes in complex vascular procedures.
• Philips: Rolled out a portable angiography unit designed for emergency departments, which improved accessibility by 18% across urban hospitals in Asia-Pacific, reducing wait times for patients.
• Shimadzu: Upgraded its angiography software platform with 3D imaging tools, now adopted by 25% of diagnostic centers, helping to increase procedural accuracy in coronary interventions.
• Boston Scientific: Expanded its interventional cardiology portfolio by integrating specialized angiography catheters, capturing 12% of the product share among minimally invasive procedure tools globally.

Report Coverage

The angiography equipment market report provides a detailed SWOT analysis covering strengths, weaknesses, opportunities, and threats shaping the industry. Strengths include over 55% adoption of digital angiography systems in hospitals and nearly 48% preference for minimally invasive diagnostics. Weaknesses lie in the high cost of equipment, with around 37% of smaller healthcare facilities delaying adoption. Opportunities are significant, with more than 45% of hospitals worldwide planning to upgrade to advanced angiography solutions and about 32% of investment targeting AI-powered diagnostic systems. Threats include workforce shortages, where nearly 36% of facilities report inadequate skilled professionals, and regulatory hurdles impacting faster adoption in emerging markets. The coverage spans across types, applications, and regional outlook, highlighting North America’s 40% dominance, Europe’s 30% adoption, Asia-Pacific’s 22% fast growth, and Middle East & Africa’s 8% emerging share. It also profiles leading players such as Siemens, GE Healthcare, and Philips, who collectively control more than 34% of the market share, while outlining innovation trends where 25% of new developments focus on radiation safety and 30% on mobile solutions. This comprehensive coverage ensures insights into market positioning, competitive strategies, and future growth potential.